Group One Trading
INBX icon

Group One Trading’s Inhibrx INBX Stock Holding History

Group One Trading’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Sell
3,129
-1,674
-35% -$168K ﹤0.01% 3957
2026
Q1 		$323K Sell
4,803
-555
-10% -$41.2K ﹤0.01% 3735
2025
Q4 		$423K Buy
+5,358
New +$365K ﹤0.01% 3689
2025
Q2 		– Sell
-3,627
Closed -$50.7K – 8250
2025
Q1 		$50.7K Buy
3,627
+3,483
+2,419% +$47.3K ﹤0.01% 5146
2024
Q4 		$2.22K Hold
144
– – ﹤0.01% 6709
2024
Q3 		$2.25K Hold
144
– – ﹤0.01% 6114
2024
Q2 		$2.04K Buy
+144
New +$2.25K ﹤0.01% 6222

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's INBX Position: Q2 2026 in Review

Group One Trading reduced its Inhibrx (INBX) stake by 35% in Q2 2026, selling an estimated $168K and leaving 3,129 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #3957.

Group One Trading first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $423K in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Group One Trading held 3,129 shares of Inhibrx worth $296K as of Q2 2026.
  • Group One Trading sold 1,674 Inhibrx shares in Q2 2026, an estimated $168K.
  • Inhibrx made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3957 holding.
  • Group One Trading first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Group One Trading's Inhibrx position peaked at $423K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.